Log In
BCIQ
Print this Print this
 

RYI-018

  Manage Alerts
Collapse Summary General Information
Company Bird Rock Bio Inc.
DescriptionCB1 inverse agonist antibody
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationNon-alcoholic steatohepatitis (NASH)
Indication DetailsTreat non-alcoholic steatohepatitis (NASH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today